查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2009178

数位病理市场规模、份额、趋势和预测：按产品、产品类型、交付模式、最终用户、应用和地区划分（2026-2034 年）

Digital Pathology Market Size, Share, Trends and Forecast by Product, Type, Delivery Model, End-User, Application, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 145 Pages | 商品交期: 2-3个工作天内

价格

2025年全球数位病理市场规模为11.095亿美元，预计到2034年将达到23.531亿美元，2026年至2034年的复合年增长率（CAGR）为8.28%。目前，北美市场占据主导地位，预计到2025年将占据超过40.7%的市场。推动该市场成长的主要因素是：随着全球慢性病盛行率的上升，人们对能够提高诊断准确性和简化工作流程的先进诊断工具的需求激增。此外，技术突破、医疗数位化进程的推进以及有利的法规结构也进一步促进了市场成长，并扩大了全球数位病理市场份额。

数位病理市场的发展动力源于对先进诊断工具日益增长的需求以及癌症等慢性疾病发病率的上升。人工智慧 (AI) 和机器学习的整合正在提高诊断准确性并简化病理学家的工作流程。例如，2024 年 9 月，罗氏扩展了其“数位病理开放环境”，整合了来自八家合作伙伴的 20 多种 AI 演算法，以改进癌症诊断。该计画旨在支持临床医生进行精准医疗，透过标靶治疗改善患者预后，并利用先进技术革新癌症研究，实现精准诊断和个人化医疗。医疗保健的数位化以及对远距病理诊断解决方案投资的增加，推动了远距医疗和第二意见的普及，进一步促进了市场应用。数位系统的监管核准以及向个人化医疗的转变也是关键因素。影像技术和云端资料储存解决方案的进步提升了扩充性，提高了可存取性，并使数位病理成为现代医疗保健基础设施的重要组成部分。

美国数位病理市场的发展主要得益于精准医疗的日益普及和医疗技术的进步。人工智慧（AI）在影像分析领域的应用不断拓展，提高了诊断效率和准确性，满足了人们对高品质患者照护日益增长的需求。癌症等慢性疾病发生率的上升也推动了对先进病理解决方案的需求。根据美国国家癌症研究所发布的数据，预计到2024年，美国将新增2,001,140例癌症病例，并有611,720例癌症相关死亡病例。摄护腺癌、肺癌和大肠癌预计将占男性癌症诊断总数的48%，而乳癌、肺癌和大肠癌预计将占女性癌症诊断总数的51%。癌症发生率为每10万人440.5例，死亡率为每10万人146例。政府措施和有利的法规结构正在加速数位化平台的普及，包括用于远距会诊的远距病理学。云端储存解决方案的整合实现了无缝的资料共用和扩充性，随着美国在医疗保健和研究数位化的大量投资，进一步推动了市场在美国的扩张。

数位病理学市场的发展趋势：

技术进步

成像技术、软体开发和整合能力的持续创新发挥着至关重要的作用。先进的成像技术提供高解析度影像，这对于精准诊断至关重要；而利用人工智慧 (AI) 和机器学习 (ML) 的复杂演算法则能提高诊断准确率、自动化繁琐任务并实现预测分析。报告显示，人工智慧在医学诊断领域的应用可望将治疗效果提升 40%，并将治疗成本降低 50%。这些进步使得患者诊断和预后评估更加快速且准确，支援远距医疗，并能够储存和管理大量数据，从而加速这些系统在全球范围内的普及。将这些技术与电子健康记录(EMR) 和实验室资讯系统 (LIS) 集成，可简化工作流程、提高临床效率、促进医疗保健领域的协作，并进一步推动数位病理市场的成长。 Proscia、PathAI、Ibex Medical Analytics、Paige 和 Clarapath 等领先企业在技术进步、建立协作式医疗保健生态系统以及推动数位病理的全球应用方面发挥了至关重要的作用。

慢性病盛行率增加

随着癌症等慢性疾病在全球范围内的日益增多，对更有效率的诊断解决方案的需求也日益迫切，而数位病理学已成为现代医学中不可或缺的工具。根据美国国家医学图书馆统计，慢性疾病在全球范围内的持续增长令人担忧，2019年慢性疾病导致的死亡人数占所有死亡人数的74%，较2010年的67%显着上升。数位病理学使病理学家能够比传统显微镜更快、更准确地分析和解读数位切片，从而加快诊断流程并改善患者预后。远距病理学支援高级组织分析，能够进行详细的检查并辅助识别疾病标记物，这对于个人化医疗和标靶治疗至关重要。此外，远距病理学能够高效处理大量病例，有效缓解病理检查室日益繁重的工作量，并支持快速准确的诊断，而这对于有效的疾病管理和治疗方案的製定至关重要。正因如此，远程病理学在对抗慢性疾病的斗争中发挥着不可或缺的作用。

远距病理诊断的需求日益增长

远距离诊断的需求比以往任何时候都更加迫切，尤其是在全球健康面临挑战的当下。远端病理学使病理学家能够不受地理限制地检查和共用高品质的数位切片，从而确保病理诊断服务的连续性。这在医疗资源匮乏的地区尤其重要，它能够提供专家会诊和第二意见，从而提高诊断的准确性。远距病理学弥合了城乡医疗设施之间的差距，使优质医疗服务的可及性更加均衡，并促进了更协作、高效和有效的医疗生态系统的发展。例如，世界卫生组织预测，到2030年，全球将出现1,000万医护人员的缺口，尤其是在低收入和中低收入国家，这催生了对远距病理学等创新解决方案的需求。数位系统的扩充性使其能够处理越来越多的切片，满足日益增长的诊断需求，同时促进更一体化和以患者为中心的医疗解决方案的发展。

目录

第一章：序言

第二章：调查方法

  • 调查目的
  • 相关利益者
  • 数据来源
    • 主要讯息
    • 次要讯息
  • 市场估值
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章执行摘要

第四章：引言

第五章：全球数位病理市场

  • 市场概览
  • 市场表现
  • 新冠疫情的影响
  • 市场预测

第六章 市场区隔：依产品划分

  • 扫描器
  • 软体
  • 储存系统
  • 通讯系统

第七章 市场区隔：依类型

  • 人类病理学
  • 兽医病理学

第八章 市场区隔：依产品/服务模式划分

  • 现场
  • 託管

第九章 市场区隔：依应用领域划分

  • 培训和教育
  • 咨询服务
  • 术中会诊
  • 日常诊断与咨询服务
  • 其他的

第十章 市场区隔：依最终用户划分

  • 製药和生物技术公司
  • 医院和检测机构
  • 学术研究机构

第十一章 市场区隔：按地区划分

  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 智利
    • 秘鲁
    • 其他的
  • 中东和非洲
    • 土耳其
    • 沙乌地阿拉伯
    • 伊朗
    • 阿拉伯聯合大公国
    • 其他的

第十二章 SWOT 分析

第十三章：价值链分析

第十四章：波特五力分析

第十五章 竞争格局

  • 市场结构
  • 主要企业
  • 主要企业简介
    • DHISTECH
    • Apollo Enterprise Imaging
    • Corista
    • Hamamatsu Photonics
    • Huron Digital Pathology
    • Indica Labs
    • Koninklijke Philips
    • Leica Biosystems
    • Objective Pathology Services
    • Ventana Medical Systems
    • Visiopharm
    • XIFIN
Product Code: SR112026A1836

The global digital pathology market size was valued at USD 1,109.5 Million in 2025. Looking forward, the market is projected to reach USD 2,353.1 Million by 2034, exhibiting a CAGR of 8.28% during 2026-2034. North America currently dominates the market, holding a significant market share of over 40.7% in 2025. The market is driven by the surging demand for advanced diagnostic tools that enhance accuracy and streamline workflows amid rising chronic disease prevalence worldwide. Additionally, technological breakthroughs, increased healthcare digitization and supportive regulatory frameworks propel market growth, further augmenting the global digital pathology market share.

The digital pathology market is driven by the rising demand for advanced diagnostic tools and the heightened incidence of chronic diseases such as cancer. The integration of artificial intelligence and machine learning enhances diagnostic accuracy and streamlining workflows for pathologists. For instance, in September 2024, Roche expanded its Digital Pathology Open Environment by incorporating more than 20 AI algorithms from eight partners, aimed at improving cancer diagnostics. This initiative aims to support clinicians in precision medicine improving patient outcomes through targeted treatments and revolutionizing cancer research with advanced technology for accurate diagnosis and personalized healthcare. Growing investments in healthcare digitization and telepathology solutions further boost market adoption enabling remote consultations and second opinions. Regulatory approvals for digital systems and the shift toward personalized medicine are also significant factors. Advancements in imaging technologies and cloud-based data storage solutions support scalability and improve accessibility making digital pathology a critical component of modern healthcare infrastructure.

The United States digital pathology market is driven by a rising focus on precision medicine and advancements in healthcare technologies. Increasing adoption of artificial intelligence for image analysis enhances diagnostic efficiency and accuracy meeting the growing demand for high-quality patient care. The rising incidence of chronic diseases, such as cancer, drives the demand for advanced pathology solutions. According to data published by the National Cancer Institute, in 2024, the U.S. is projected to have 2,001,140 new cancer cases and 611,720 cancer-related deaths. Prostate, lung and colorectal cancers will account for 48% of diagnoses in men while breast, lung and colorectal cancers will make up 51% in women. The cancer incidence rate is 440.5 per 100,000 people, with a mortality rate of 146.0. Government initiatives and favorable regulatory frameworks accelerate the adoption of digital platforms including telepathology for remote consultations. The integration of cloud-based storage solutions enables seamless data sharing and scalability while significant investments in healthcare digitization and research further support the market's expansion across the country.

DIGITAL PATHOLOGY MARKET TRENDS:

Technological advancements

The relentless pace of innovation in imaging techniques, software development and integration capabilities has been pivotal. Enhanced imaging technologies offer high-resolution images essential for accurate diagnosis while sophisticated algorithms powered by artificial intelligence (AI) and machine learning (ML) improve diagnostic precision, automate tedious tasks and enable predictive analytics. According to reports, AI in medical diagnosis has the potential to improve health outcomes by 40% and lower treatment costs by 50%.These advancements facilitate faster and more accurate patient diagnoses and prognoses which in turn support remote consultations and enable vast data storage and management thus driving the adoption of this systems globally. The integration of this with electronic medical records (EMRs) and laboratory information systems (LIS) streamlines workflows, enhances clinical efficiency, and fosters a more collaborative approach to healthcare further propelling the digital pathology market growth. Some of the key players include Proscia, PathAI, Ibex Medical Analytics, Paige, and Clarapath, who have been instrumental in advancing these technologies, fostering collaborative healthcare ecosystems and accelerating the adoption of digital pathology globally.

Increasing prevalence of chronic diseases

The global increase in chronic illnesses such as cancer demands more efficient diagnostic solutions, positioning it as a crucial tool in modern healthcare. According to National Library of Medicine, the global rise in chronic illnesses, responsible for 74% of all deaths in 2019, highlights an alarming increase from 67% in 2010. It enables pathologists to analyze and interpret digital slides with greater speed and precision compared to traditional microscopy, thereby accelerating the diagnostic process and improving patient outcomes. It supports advanced tissue analysis, enabling detailed examination and aiding in the identification of disease markers, which is vital for personalized medicine and targeted therapies. Its capacity for managing large volumes of cases effectively addresses the growing workload in pathology labs, thereby supporting the rapid and accurate diagnosis necessary for effective disease management and treatment planning, making it indispensable in the fight against chronic diseases.

Growing demand for telepathology

The need for remote diagnostics has never been more pronounced, especially in the wake of global health challenges. It facilitates telepathology, allowing pathologists to examine and share high-quality digital slides irrespective of geographical constraints, thus ensuring uninterrupted pathology services. This is particularly advantageous for regions with limited access to specialized healthcare services, enabling expert consultation and second opinions that enhance diagnostic accuracy. Telepathology bridges the gap between rural and urban healthcare facilities, democratizing access to high-quality medical services and fostering a more collaborative, efficient, and effective healthcare ecosystem. For instance, WHO projects a shortage of 10 Million health workers by 2030, particularly in low- and lower-middle-income countries creating demand for innovative solution like telepathology. The scalability of digital systems allows for the handling of increasing slide volumes, catering to growing diagnostic demands while promoting more integrated and patient-centric healthcare solutions.

DIGITAL PATHOLOGY INDUSTRY SEGMENTATION:

Analysis by Product:

  • Scanners
  • Software
  • Storage Systems
  • Communication Systems

Scanners leads the market due to their critical role in digitizing histopathological slides for analysis, storage, and sharing. These devices range from high-throughput models designed for large laboratories to more compact versions for smaller settings, all aiming to deliver high-resolution images that retain the nuances of traditional microscopy. The advancement in scanning technologies has significantly reduced the time and cost per slide, enabling a seamless transition from analog to digital formats. This shift is instrumental in accommodating the growing volume of pathology samples, driven by an increase in cancer cases and other chronic diseases that necessitate detailed tissue analysis. Furthermore, the integration of scanners with AI and ML algorithms has facilitated new methods for automated image analysis, increasing diagnostic precision and effectiveness. As the cornerstone of this, scanners continue to improve, incorporating faster scanning speeds, higher image resolutions, and improved usability, ensuring their dominance in the market.

Analysis by Type:

  • Human Pathology
  • Veterinary Pathology

Human Pathology leads the market with around 62.2% of digital pathology market share in 2025. Human pathology plays a pivotal role in modern healthcare by enabling the detailed examination and analysis of human tissue samples. This segment has gained substantial momentum due to its crucial role in diagnosing a wide array of human diseases, especially cancer, where precision and timely diagnosis are vital. The integration of advanced imaging technologies, AI, and machine learning algorithms has significantly enhanced the accuracy, efficiency, and speed of pathological analysis, leading to improved patient outcomes. These technologies facilitate the detailed examination of slides, enabling pathologists to detect diseases at earlier stages and with greater precision. Furthermore, human pathology benefits immensely from digital archiving, which improves data retrieval and sharing, supporting collaborative diagnostics and research globally. The ability to quickly share high-resolution images across locations has also been instrumental in advancing telepathology, making specialized diagnostic expertise more accessible and facilitating second opinions, thereby enhancing the quality of care and patient management.

Analysis by Delivery Model:

  • On-premises
  • Hosted

The on-premises delivery model offers substantial control over the infrastructure and data, a critical factor for many healthcare organizations. This model involves the installation of software and hardware within the premises of the organization, ensuring robust data security and privacy, as it allows sensitive patient data to remain within the institution's firewall. It is particularly favored by large healthcare institutions and research facilities that prioritize data control, require high-speed access to large image files, and can afford the significant upfront investment in infrastructure. The on-premises model also facilitates compliance with stringent regulatory standards, as healthcare providers can directly oversee the management and security of the data.

Analysis by Application:

  • Training and Education
  • Consulting Services
  • Intraoperative Consultation
  • Routine Diagnostic Consultation Services
  • Others

Routine diagnostic consultation services represent the core application of this in everyday healthcare practices. This segment encompasses the use of this is for standard diagnostic evaluations, where pathologists review digitized slide images to detect, diagnose, and provide prognostic information on various diseases, primarily cancer. The integration of this in routine diagnostics significantly enhances the efficiency, accuracy, and speed of diagnostic processes. It allows for the storage of vast amounts of digital slides and associated data, facilitating easier data retrieval, long-term case study, and educational use. The technology's ability to enable quick sharing of digital slides and collaborative diagnostics also supports multi-disciplinary team meetings, ensuring comprehensive patient care.

Analysis by End-User:

  • Pharmaceutical & Biotechnology Companies
  • Hospitals and Reference Laboratories
  • Academic & Research Institutes

Academic and research institutes leads the market with around 45.7% of market share in 2025. Academic and research institutes represent the education, research, and diagnostic applications. The adoption of this in these institutes facilitates comprehensive educational programs, allowing students and trainees to access a wealth of digital slides and participate in interactive learning environments. It significantly enhances research capabilities, providing researchers with the tools to perform detailed morphological analyses, quantitative assessments, and high-throughput image analysis. This is crucial for advancing our understanding of disease pathology, developing novel therapeutic strategies, and contributing to the body of scientific knowledge.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Others
  • Middle East and Africa
    • Turkey
    • Saudi Arabia
    • Iran
    • United Arab Emirates
    • Others

In 2025, North America accounted for the largest market share of over 40.7%. North America region boasts high-tech healthcare infrastructure, high adoption of digital imaging solutions, and significant investments in healthcare IT. The presence of prominent market players who consistently innovate in AI and machine learning technologies drives the dynamic growth of this sector. Furthermore, the region's strong emphasis on cancer research, coupled with substantial funding for oncology studies, propels the demand for this is to enable quick, accurate diagnoses and research applications. Regulatory support from bodies like the FDA, which has been progressively approving this system for diagnostic use, also plays a crucial role.. Additionally, the increasing shift towards personalized medicine in North America requires comprehensive tissue analyses, thereby driving the adoption of these solutions.

KEY REGIONAL TAKEAWAYS:

UNITED STATES DIGITAL PATHOLOGY MARKET ANALYSIS

In 2025, United States accounted for a share of 89.80% of the North America market. In the United States the adoption of digital pathology is significantly influenced by the expansion of sophisticated healthcare systems. As healthcare infrastructure evolves with cutting-edge technologies such as advanced imaging and data analytics there is an increasing shift towards incorporating digital pathology for more efficient diagnostic processes. For instance, venture-capital investments in health AI in the United States are set to hit USD 11 Billion this year fuelling advancements in healthcare infrastructure. These developments are pivotal for enhancing digital pathology modifying diagnostic capabilities and workflow efficiency. The integration of high-performance computing, cloud-based systems and artificial intelligence further enhances the ability to store, analyze and share pathology data promoting collaboration and improving diagnostic accuracy. These developments foster an environment where healthcare providers can better manage and interpret vast volumes of patient data, driving faster and more precise diagnoses. Additionally, healthcare institutions are continuously expanding their capabilities with state-of-the-art equipment reinforcing the trend toward digital pathology as an essential tool for enhancing diagnostic workflows.

ASIA PACIFIC DIGITAL PATHOLOGY MARKET ANALYSIS

In the Asia-Pacific region the ongoing digital transformation in the healthcare sector plays a pivotal role in the rise of digital pathology adoption. According to reports, 79% of innovations among Indian MedTech start-ups focus on medical technology solutions with 63% integrating digital advancements. This growing trend is particularly beneficial for Digital Pathology enhancing diagnostic precision and accessibility. Governments and private healthcare providers are increasingly focusing on incorporating digital tools aiming to streamline medical processes, reduce costs and improve the quality of care. As healthcare systems modernize and adopt more electronic health records, imaging technologies and telemedicine services the transition to digital pathology becomes more seamless. Moreover, the growing emphasis on healthcare accessibility and affordability encourages the integration of digital pathology solutions to bridge gaps in medical services especially in rural and underserved areas leading to better patient outcomes.

EUROPE DIGITAL PATHOLOGY MARKET ANALYSIS

In Europe, the growing prevalence of chronic illnesses is a key driver in the increased adoption of digital pathology. As the region faces a rising burden of conditions such as cancer, cardiovascular diseases and diabetes there is a significant demand for more precise and timely diagnostic tools. For instance, in the UK, 395,181 cancer cases were diagnosed in 2021 highlighting the increasing demand for advanced diagnostic tools. This growing trend is driving the adoption of digital pathology offering more efficient and accurate cancer detection. Digital pathology enables the use of advanced imaging techniques and data-driven insights allowing for more accurate detection and personalized treatment plans. With the need for improved diagnostic efficiency in managing chronic diseases healthcare providers are increasingly turning to digital pathology to enhance workflow, reduce errors and expedite diagnosis resulting in better management of these long-term health conditions.

LATIN AMERICA DIGITAL PATHOLOGY MARKET ANALYSIS

In Latin America, the increasing availability of disposable income among the population is accelerating the adoption of digital pathology. For instance, total disposable income in Latin America is projected to grow by nearly 60% from 2021 to 2040 driven by regional equality, technological progress and sectoral shifts benefiting the expansion of digital healthcare services. As individuals in the region experience rising economic prosperity there is a greater ability to access advanced healthcare services including digital diagnostic tools. Healthcare institutions are upgrading their facilities to include digital pathology solutions offering enhanced precision and efficiency in diagnoses. This financial growth supports the widespread implementation of digital solutions in medical practices allowing patients to benefit from quicker more accurate diagnostic results and fostering a healthier population overall.

MIDDLE EAST AND AFRICA DIGITAL PATHOLOGY MARKET ANALYSIS

In the Middle East and Africa, the development of healthcare infrastructure is promoting the widespread adoption of digital pathology technologies . According to Dubai Healthcare City Authority report, by 2022, Dubai saw 4,482 private medical facilities including 56 hospitals and 55,208 licensed medical professionals. The projected 10-15% growth in medical professionals and 3-6% increase in facilities will enhance the adoption of digital pathology improving healthcare services and diagnostic capabilities. As healthcare infrastructure continues to grow in these regions particularly in urban areas there is an increasing integration of advanced diagnostic tools to meet the rising demand for high-quality medical care. With a focus on modernizing hospitals and medical centres there is greater investment in digital pathology systems that can enhance the speed, accuracy and collaboration in diagnosing a wide range of diseases. The improved access to state-of-the-art healthcare facilities makes digital pathology more accessible and increasingly prevalent benefiting both patients and healthcare providers.

COMPETITIVE LANDSCAPE:

The digital pathology market is marked by intense competition driven by technological advancements and the growing adoption of AI-powered diagnostic tools. Companies focus on enhancing image analysis, data integration and cloud-based solutions to streamline pathology workflows and improve diagnostic accuracy. The market sees strong collaboration between technology providers, healthcare institutions and research organizations to develop scalable and interoperable systems. For instance, in July 2024, AGFA HealthCare launched its integrated solution Enterprise Imaging for Pathology powered by Corista DP3 in North America. Designed by pathologists for pathologists it enhances digital workflow, efficiency, data management and collaboration addressing the transition from analog to digital pathology. Increasing demand for telepathology and remote consultation capabilities further fuels innovation. Regulatory approvals and conformity with healthcare standards play a key role in enabling market players to obtain a competitive advantage.. The push for personalized medicine and improved patient outcomes motivates continuous research and development positioning digital pathology as a vital component in modern diagnostics and healthcare infrastructure.

The report provides a comprehensive analysis of the competitive landscape in the digital pathology market with detailed profiles of all major companies, including:

  • DHISTECH
  • Apollo Enterprise Imaging
  • Corista
  • Hamamatsu Photonics
  • Huron Digital Pathology
  • Indica Labs
  • Koninklijke Philips
  • Leica Biosystems
  • Objective Pathology Services
  • Ventana Medical Systems
  • Visiopharm
  • XIFIN

KEY QUESTIONS ANSWERED IN THIS REPORT

1. How big is the global digital pathology market?

2. What is the expected growth rate of the global digital pathology market during 2026-2034?

3. What are the key factors driving the global digital pathology market?

4. What is the leading segment of the global digital pathology market based on product?

5. Who are the key players/companies in the global digital pathology market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Digital Pathology Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Scanners
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Software
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Storage Systems
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Communication Systems
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Type

  • 7.1 Human Pathology
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Veterinary Pathology
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Delivery Model

  • 8.1 On-premises
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Hosted
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Training and Education
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Consulting Services
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Intraoperative Consultation
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Routine Diagnostic Consultation Services
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Others
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market Breakup by End-User

  • 10.1 Pharmaceutical & Biotechnology Companies
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Hospitals and Reference Laboratories
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Academic & Research Institutes
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Europe
    • 11.2.1 Germany
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 France
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 United Kingdom
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 Italy
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Spain
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Russia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Asia Pacific
    • 11.3.1 China
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 Japan
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 India
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 South Korea
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Australia
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Indonesia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Argentina
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
    • 11.4.4 Colombia
      • 11.4.4.1 Market Trends
      • 11.4.4.2 Market Forecast
    • 11.4.5 Chile
      • 11.4.5.1 Market Trends
      • 11.4.5.2 Market Forecast
    • 11.4.6 Peru
      • 11.4.6.1 Market Trends
      • 11.4.6.2 Market Forecast
    • 11.4.7 Others
      • 11.4.7.1 Market Trends
      • 11.4.7.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Turkey
      • 11.5.1.1 Market Trends
      • 11.5.1.2 Market Forecast
    • 11.5.2 Saudi Arabia
      • 11.5.2.1 Market Trends
      • 11.5.2.2 Market Forecast
    • 11.5.3 Iran
      • 11.5.3.1 Market Trends
      • 11.5.3.2 Market Forecast
    • 11.5.4 United Arab Emirates
      • 11.5.4.1 Market Trends
      • 11.5.4.2 Market Forecast
    • 11.5.5 Others
      • 11.5.5.1 Market Trends
      • 11.5.5.2 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 DHISTECH
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Apollo Enterprise Imaging
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Corista
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Hamamatsu Photonics
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
    • 15.3.5 Huron Digital Pathology
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Indica Labs
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Koninklijke Philips
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Leica Biosystems
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 Objective Pathology Services
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Ventana Medical Systems
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 Visiopharm
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
    • 15.3.12 XIFIN
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio

List of Figures

  • Figure 1: Global: Digital Pathology Market: Major Drivers and Challenges
  • Figure 2: Global: Digital Pathology Market: Sales Value (in Million USD), 2020-2025
  • Figure 3: Global: Digital Pathology Market: Breakup by Product (in %), 2025
  • Figure 4: Global: Digital Pathology Market: Breakup by Type (in %), 2025
  • Figure 5: Global: Digital Pathology Market: Breakup by Delivery Model (in %), 2025
  • Figure 6: Global: Digital Pathology Market: Breakup by Application (in %), 2025
  • Figure 7: Global: Digital Pathology Market: Breakup by End-User (in %), 2025
  • Figure 8: Global: Digital Pathology Market: Breakup by Region (in %), 2025
  • Figure 9: Global: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Digital Pathology (Scanners) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Digital Pathology (Scanners) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Digital Pathology (Software) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Digital Pathology (Software) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Digital Pathology (Storage Systems) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Digital Pathology (Storage Systems) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Digital Pathology (Communication Systems) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Digital Pathology (Communication Systems) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Digital Pathology (Human Pathology) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Digital Pathology (Human Pathology) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Digital Pathology (Veterinary Pathology) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Digital Pathology (Veterinary Pathology) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Digital Pathology (On-premises) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Digital Pathology (On-premises) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Digital Pathology (Hosted) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Digital Pathology (Hosted) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Digital Pathology (Training and Education) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Digital Pathology (Training and Education) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Global: Digital Pathology (Consulting Services) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Global: Digital Pathology (Consulting Services) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Global: Digital Pathology (Intraoperative Consultation) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Global: Digital Pathology (Intraoperative Consultation) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Global: Digital Pathology (Routine Diagnostic Consultation Services) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Global: Digital Pathology (Routine Diagnostic Consultation Services) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Global: Digital Pathology (Others) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Global: Digital Pathology (Others) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: Global: Digital Pathology (Pharmaceutical & Biotechnology Companies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: Global: Digital Pathology (Pharmaceutical & Biotechnology Companies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: Global: Digital Pathology (Hospitals and Reference Laboratories) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: Global: Digital Pathology (Hospitals and Reference Laboratories) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: Global: Digital Pathology (Academic & Research Institutes) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: Global: Digital Pathology (Academic & Research Institutes) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: North America: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: North America: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: United States: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: United States: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Canada: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Canada: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Europe: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Europe: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Germany: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Germany: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: France: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: France: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: United Kingdom: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: United Kingdom: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Italy: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Italy: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Spain: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Spain: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Russia: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Russia: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Others: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Others: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Asia Pacific: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Asia Pacific: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: China: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: China: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Japan: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Japan: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: India: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: India: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: South Korea: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: South Korea: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Australia: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Australia: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 76: Indonesia: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 77: Indonesia: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 78: Others: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 79: Others: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 80: Latin America: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 81: Latin America: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 82: Brazil: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 83: Brazil: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 84: Mexico: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 85: Mexico: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 86: Argentina: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 87: Argentina: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 88: Colombia: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 89: Colombia: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 90: Chile: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 91: Chile: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 92: Peru: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 93: Peru: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 94: Others: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 95: Others: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 96: Middle East and Africa: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 97: Middle East and Africa: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 98: Turkey: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 99: Turkey: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 100: Saudi Arabia: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 101: Saudi Arabia: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 102: Iran: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 103: Iran: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 104: United Arab Emirates: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 105: United Arab Emirates: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 106: Others: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 107: Others: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 108: Global: Digital Pathology Industry: SWOT Analysis
  • Figure 109: Global: Digital Pathology Industry: Value Chain Analysis
  • Figure 110: Global: Digital Pathology Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Digital Pathology Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Digital Pathology Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 3: Global: Digital Pathology Market Forecast: Breakup by Type (in Million USD), 2026-2034
  • Table 4: Global: Digital Pathology Market Forecast: Breakup by Delivery Model (in Million USD), 2026-2034
  • Table 5: Global: Digital Pathology Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 6: Global: Digital Pathology Market Forecast: Breakup by End-User (in Million USD), 2026-2034
  • Table 7: Global: Digital Pathology Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 8: Global: Digital Pathology Market Structure
  • Table 9: Global: Digital Pathology Market: Key Players